The winners were announced at the finale held in Bengaluru, in the presence of Kiran Mazumdar-Shaw, Executive Chairperson, Biocon Limited. The research will focus on disease-progression modelling, predictive outcome modelling and advanced clinical trial simulations. The initiative will initially focus on patients with desmoid tumors and neurofibromatosis type 1 with plexiform neurofibromas. The initiative aims to address persistent gaps in healthcare, including late diagnosis, delays in specialist referrals.